FDA-NIH Workshop: Reducing Animal Testing July 7, 2025

Workshop | In Person

---

• Date: July 7, 2025
• Time: 10:00 a.m. - 2:00 p.m. ET

---

Background: On Monday, July 7, 2025, the FDA hosted a hybrid workshop on reducing animal testing. The agenda focused on implementing novel methodologies and other strategies to reduce the use of animal testing. Featured speakers from the FDA, NIH and representatives from international regulatory bodies discussed successes, challenges and ideas for implementation.

Event Materials: Agenda

---

Panelists:
FDA

• Marty Makary, M.D., M.P.H. 
  FDA Commissioner  
• Tracy Beth Høeg, M.D., Ph.D. 
  Senior Advisor for Clinical Sciences, Office of the Commissioner & Center for Biologics Evaluation and Research  
• Jacqueline Corrigan-Curay, J.D, M.D. 
  Acting Director, Center for Drug Evaluation and Research 
• Haleh Saber, Ph.D. 
  Division Director of Hematology, Oncology and Toxicology, Center for Drug Evaluation and Research 
• Steven Musser, Ph.D.  
  Associate Commissioner for Human Foods Research  
• Jeremy Walsh  
  Chief Artificial Intelligence Officer  
• Tucker Patterson, Ph.D.  
  Director, National Center for Toxicological Research 
• Steve Kozlowski, M.D. 
  Acting Chief Scientist 
• Tracy Chen, Ph.D., D.A.B.T. 
  Senior Advisor, Regulatory Science Collaborative Community, Office of the Chief Scientist  

NIH and ARPA-H 

• Nicole Kleinstreuer, Ph.D.  
  Acting NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health  
• Warren Casey, Ph.D., DABT 
  Director of Strategic Partnerships in the Office of Portfolio Strategy and Research Management, Division of Translational Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health  
• Brian Cholewa, Ph.D. 
  Senior Toxicologist/Program Director, Chemopreventive Agent Development Research Group, National Cancer Institute, National Institutes of Health  
• Andrew Kilianski, Ph.D. 
  Acting Deputy Director, Health Science Futures, Advanced Research Projects Agency for Health (ARPA-H) 

International Regulators 

• Sonja Beken, Ph.D. 
  MSc Chair 3 Rs Working Party (3RsWP), European Medicines Agency (EMA) (Belgium) 
• Philip Marx-Stoelting, Ph.D. 
  Scientific Director, Testing and Assessment Strategies, Pesticides Safety Department, German Federal Institute for Risk Assessment (BfR or Bundesintitut fur Risikobewertung) (Germany) 
• Mineo Matsumoto, Ph.D. 
  Associate Senior Scientist for Toxicology, Office of New Drug V, Pharmaceuticals and Medical Devices Agency (PMDA) with 
  Jihei Nishimura, Ph.D. 
  Associate Senior Scientist for Toxicology, Office of New Drug IV, Pharmaceuticals and Medical Devices Agency (PMDA) (Japan) 
• Colin Clyne, Ph.D., B.Sc. 
  Senior Toxicologist, Therapeutic Goods Administration (Australia)